A1 Refereed original research article in a scientific journal

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo




AuthorsBentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P, Køber LV, Lawson F, Lewis EF, Maggioni AP, McMurray JJ, Ping L, Probstfield JL, Solomon SD, Tardif JC, Wu Y, Pfeffer MA; for the ELIXA Investigators

Publication year2015

Journal:American Heart Journal

Volume169

Issue5

First page 631

Last page638

Number of pages8

ISSN0002-8703

DOIhttps://doi.org/10.1016/j.ahj.2015.02.002




Last updated on 2024-26-11 at 22:04